BHOC definition and strategy
Biological Hemoglobin Oxygen Carrier positioning within Precision Oxygen Therapeutics and the wider oxygen-delivery field.
BHOC Therapeutics
Archil Jaliashvili
Biotechnology and oxygen therapeutics executive
Archil Jaliashvili leads the public scientific and strategic development work across BHOC Therapeutics, the BHOC Scientific Evidence Hub and connected veterinary evidence resources.
One identity across the BHOC information ecosystem.
The work is organized around a clear definition: BHOC means Biological Hemoglobin Oxygen Carrier. The framework places oxygen delivery, tissue physiology, evidence traceability and translational context before therapeutic claims.
BHOC Therapeutics is the official company-facing site. The BHOC Scientific Evidence Hub maintains source-linked scientific, clinical, regulatory and historical material. BHOC Veterinary organizes veterinary and species-specific context.
BHOC materials are scientific, educational and developmental. They do not describe an approved therapeutic indication and do not present BHOC as a replacement for the wider biological functions of blood.
Evidence architecture
Source-linked organization of human, veterinary, preclinical, regulatory, historical and real-world evidence.
Translation across species
Clear separation of human and veterinary evidence while connecting shared oxygen-delivery questions.